YDES
YD Bio LtdCompany with tickers: YDES, YDESW
CIK
2011674
CUSIP
G98301107
Shares Outstanding
70,831,346
13F Activity (30d)
8 filings
6 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $596,817 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $429,407 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Gross Profit | $167,410 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Operating Expenses | $5,439,131 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Research & Development | $1,602,064 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Operating Income | $-5,271,721 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| Net Income | $-8,311,316 | USD | 2025-12-31 | 20-F | 2026-04-30 |
| EPS (Basic) | $-0.12 | USD/shares | 2025-12-31 | 20-F | 2026-04-30 |
| EPS (Diluted) | $-0.12 | USD/shares | 2025-12-31 | 20-F | 2026-04-30 |